[Effectiveness of nystatin G in treatment of vaginal mycosis (author's transl)].
Nystatin G has proved to be an excellent antimycotic in suppository form, its concentration of active principle being 200,000 I.U. Mycoses were brought under complete control in 88 per cent of 75 patients by one single cycle of treatment, during which one suppository was inserted daily over ten consecutive days. Primary therapy failed in twelve per cent. Most of those patients had been using hormonal contraceptives over many years or were pregnant. Full therapeutic effect, basically, depends on successful treatment of the rectum on treatment of the partner.
D002175:Candida; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D009761:Nystatin / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D014623:Vaginal Diseases / Q000188:drug therapy*
D009761:Nystatin
Die Wirksamkeit des Nystatin G bei der Behandlung von Vaginalmykosen.